Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

Sponsor
The Second Affiliated Hospital of Chongqing Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05670561
Collaborator
(none)
60
1
2
7
8.6

Study Details

Study Description

Brief Summary

Pain is the main complication after TACE(Transcatheter Arterial Chemoembolization) for hepatocellular carcinoma, and its pathogenesis is not clear.The pain may be related to partial liver tissue swelling after blocking the tumor blood supply artery embolization agent, transient hepatic swelling causing tension or strain on the liver capsule, and chemical irritation by the anticancer drug-Lipiodol mixture,the inadvertent embolization of normal organs and individual sensitivity to pain. Ketamine produces anesthetic and analgesic effects mainly by inhibiting NMDA receptor(N-methyl-D-aspartic acid receptor), and previous studies have shown that low concentrations of ketamine have obvious analgesic effects. Not only that, ketamine also produces analgesic effects by inhibiting opioid receptors via G-protein coupling. In addition, ketamine can bind to monoaminergic receptors in the central and peripheral nervous system, showing an anticholinergic effect and producing an antispasmodic effect. Ketamine also inhibits inflammatory pain by reducing nitric oxide production by inhibiting nitric oxide synthase. Esketamine is about three to four times more potent than ketamine. Therefore,esketamine requires a lower dose, about half the dose of ketamine, to produce anesthetic and analgesic effects, with fewer side effects.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma:a Prospective Study TACE(Transcatheter Arterial Chemoembolization)
Anticipated Study Start Date :
Dec 30, 2022
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jul 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Esketamine-PCIA(patient controlled intravenous analgesia)

PCIA formula#100ml analgesic solution was prepared by adding 2.5 mg/kg Esketamine and 8mg ondansetron into normal saline.

Drug: Esketamine
PCIA formula#100ml analgesic solution was prepared by adding 2.5 mg/kg Esketamine and 8mg ondansetron into normal saline. 30min before TACE treatment, the first dose of 2ml was slowly injected intravenously. No obvious adverse reactions were observed for 10min.The PCIA pump was commenced at the beginning of TACE. Parameter setting of intravenous analgesia pump: the total volume is 100ml; The duration is 2ml / h; The single dose is 2ml each time; The limit quantity is 10ml / h; The locking time was 10min and the analgesia lasted for 48h. The target value of analgesia in this study was NRS (Numerical Rating Scale)< 4; If NRS ≥ 4, when the effect is still poor after adding drugs by pressing the analgesic pump, the investigators will give the remedial drug(dolantin 50mg im st) according to the patient's condition.
Other Names:
  • patient controlled intravenous analgesia
  • Active Comparator: Sufentanil-PCIA(patient controlled intravenous analgesia)

    PCIA formula#100ml analgesic solution was prepared by adding 2 μ g/kg sufentanil and 8mg ondansetron into normal saline.

    Drug: Sufentanil
    PCIA formula#100ml analgesic solution was prepared by adding 2 μ g/kg sufentanil and 8mg ondansetron into normal saline. 30min before TACE treatment, the first dose of 2ml was slowly injected intravenously.No obvious adverse reactions were observed for 10min. The PCIA pump was commenced at the beginning of TACE. Parameter setting of intravenous analgesia pump: the total volume is 100ml; The duration is 2ml / h; The single dose is 2ml each time; The limit quantity is 10ml / h; The locking time was 10min and the analgesia lasted for 48h. The target value of analgesia in this study was NRS (Numerical Rating Scale)< 4; If NRS ≥ 4, when the effect is still poor after adding drugs by pressing the analgesic pump, the investigators will give the remedial drug(dolantin 50mg im st) according to the patient's condition.
    Other Names:
  • patient controlled intravenous analgesia
  • Outcome Measures

    Primary Outcome Measures

    1. Pain Intensity at 4hours after the beginning of TACE operation [From 0 to 4hours after the beginning of TACE]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    2. Pain Intensity at 8hours after the beginning of TACE operation [From 4hours to 8hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    3. Pain Intensity at 12hours after the beginning of TACE operation [From 8hours to 12hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    Secondary Outcome Measures

    1. Pain Intensity at 18hours after the beginning of TACE operation [From 12hours to 18hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    2. Pain Intensity at 24hours after the beginning of TACE operation [From 18hours to 24hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    3. Pain Intensity at 30hours after the beginning of TACE operation [From 24hours to 30hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    4. Pain Intensity at 36hours after the beginning of TACE operation [From 30hours to 36hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    5. Pain Intensity at 42hours after the beginning of TACE operation [From 36hours to 42hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    6. Pain Intensity at 48hours after the beginning of TACE operation [From 42hours to 48hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    7. Maximum Pain Intensity in the First 4hours after the beginning of TACE operation [From the beginning of TACE operation to 4hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    8. Maximum Pain Intensity in the Second 4hours after the beginning of TACE operation [From 4hours to 8hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    9. Maximum Pain Intensity in the Third 4hours after the beginning of TACE operation [From 8hours to 12hours after the beginning of TACE operation]

      Pain intensity is assessed by numerical rating scale pain scores(0-10,0 represents painless,10 represents intolerable pain;higher scores mean a worse outcome)

    10. Analgesic Consumption [From 0 to 48 hours after the beginning of TACE operation]

      Analgesic consumption is assessed by the total amount of pain remedy with dolantin when the analgesic effect is poor.

    Other Outcome Measures

    1. Ramsay Sedation Score at 1 hour after the beginning of TACE operation [From 0 to 1hour after the beginning of TACE operation]

      Grade 1 (soberness- the patient is anxious, uneasy or irritable)# Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)# Grade 3 (soberness- the patient only responds to commands)# Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)# Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation.

    2. Ramsay Sedation Score at 2 hours after the beginning of TACE operation [From 1hour to 2hours after the beginning of TACE operation]

      Grade 1 (soberness- the patient is anxious, uneasy or irritable)# Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)# Grade 3 (soberness- the patient only responds to commands)# Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)# Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation.

    3. Ramsay Sedation Score at 3 hours after the beginning of TACE operation [From 2hours to 3hours after the beginning of TACE operation]

      Grade 1 (soberness- the patient is anxious, uneasy or irritable)# Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)# Grade 3 (soberness- the patient only responds to commands)# Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)# Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation.

    4. The Quality of Sleep on the Day Just before TACE Treatment [From the day just before TACE treatment to the operation day]

      The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome)

    5. The Quality of Sleep on the Operation Day [From the operation day to first day after TACE treatment]

      The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome)

    6. The Quality of Sleep on the First Day after TACE Treatment [From the first day after TACE treatment to the second day after TACE treatment]

      The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome)

    7. Adverse Reaction [From 0 to 48 hours after the beginning of TACE operation]

      Adverse reaction is recorded according to follow-up visits after HAIC treatment

    8. Degree of Satisfaction [From 0 to 24 hours after the beginning of TACE operation]

      Degree of satisfaction is assessed by patient using numerical rating scale (0-10, 0 represents unsatisfactory; 10 represents complete satisfaction;higher scores mean a better outcome)

    9. Quality-of-Life Assessment at the the beginning of TACE operation [From the beginning of TACE operation to 0 hour after the beginning of TACE operation]

      Quality-of-life contains patients' quality of sleep,fatigue, spiritual well-being, and appetite.The scores were categorized as follows: 1,worst;2,bad;3, mild;4, normal;5,very good.

    10. Quality-of-Life Assessment at 24hours after the beginning of TACE operation [From 0 to 24 hours after the beginning of TACE operation]

      Quality-of-life contains patients' quality of sleep,fatigue, spiritual well-being, and appetite.The scores were categorized as follows: 1,worst;2,bad;3, mild;4, normal;5,very good.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18 to 80

    • Participate in this study and sign informed consent

    • Voluntarily receive preoperative intravenous analgesia

    • Patients receiving TACE treatment

    • HCC (hepatocellular carcinoma)patients with primary liver cancer BCLC(Barcelona Clinic Liver Cancer) stage B and C, liver function A

    Exclusion Criteria:
    • Patients who were unable to cooperate or refused to participate in the trial

    • Pregnant women

    • Patients with or having a history of serious mental disorders

    • Patients with poorly controlled or untreated hypertension (arterial hypertension, resting systolic / diastolic blood pressure more than 180/100mg)

    • Patients with unstable angina pectoris or myocardial infarction within 6 months or congestive heart failure

    • Patients with intracranial hypertension or glaucoma

    • Patients with hyperthyroidism without treatment or insufficient treatment

    • Patients with severe respiratory dysfunction

    • Allergy or existing contraindication to chemotherapeutic drugs, opioids or ketamine drugs

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Second Affiliated Hospital, Chongqing Medical University Chongqing Chongqing China 400010

    Sponsors and Collaborators

    • The Second Affiliated Hospital of Chongqing Medical University

    Investigators

    • Study Chair: Huang He, MD, The Second Affiliated Hospital, Chongqing Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The Second Affiliated Hospital of Chongqing Medical University
    ClinicalTrials.gov Identifier:
    NCT05670561
    Other Study ID Numbers:
    • pain after TACE
    First Posted:
    Jan 4, 2023
    Last Update Posted:
    Jan 4, 2023
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 4, 2023